How are ATR strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the ATR strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 26.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$365.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a ATR strangle?

The breakeven for the ATR strangle priced on this page is roughly $106.35 and $123.65 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ATR market-implied 1-standard-deviation expected move is approximately 7.60%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current ATR implied volatility affect this strangle?

ATR ATM IV is at 26.50% with IV rank near 8.51%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

ATR Strangle Strategy

ATR (AptarGroup, Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NYSE.

AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America.

ATR (AptarGroup, Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $7.52B, a trailing P/E of 19.53, a beta of 0.42 versus the broader market, a 52-week range of 103.23-164.28, average daily share volume of 513K, a public-listing history dating back to 1993, approximately 13K full-time employees. These structural characteristics shape how ATR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.42 indicates ATR has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. ATR pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a strangle on ATR?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current ATR snapshot

As of May 15, 2026, spot at $114.83, ATM IV 26.50%, IV rank 8.51%, expected move 7.60%. The strangle on ATR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this strangle structure on ATR specifically: ATR IV at 26.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a ATR strangle, with a market-implied 1-standard-deviation move of approximately 7.60% (roughly $8.72 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ATR expiries trade a higher absolute premium for lower per-day decay. Position sizing on ATR should anchor to the underlying notional of $114.83 per share and to the trader's directional view on ATR stock.

ATR strangle setup

The ATR strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ATR near $114.83, the first option leg uses a $120.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ATR chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ATR shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$120.00	$1.85
Buy 1	Put	$110.00	$1.80

ATR strangle risk and reward

Net Premium / Debit: -$365.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$365.00
Breakeven(s): $106.35, $123.65
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

ATR strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on ATR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$10,634.00
$25.40	-77.9%	+$8,095.16
$50.79	-55.8%	+$5,556.31
$76.18	-33.7%	+$3,017.47
$101.56	-11.6%	+$478.62
$126.95	+10.6%	+$330.22
$152.34	+32.7%	+$2,869.07
$177.73	+54.8%	+$5,407.91
$203.12	+76.9%	+$7,946.75
$228.51	+99.0%	+$10,485.60

When traders use strangle on ATR

Strangles on ATR are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the ATR chain.

ATR thesis for this strangle

The market-implied 1-standard-deviation range for ATR extends from approximately $106.11 on the downside to $123.55 on the upside. A ATR long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current ATR IV rank near 8.51% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ATR at 26.50%. As a Healthcare name, ATR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ATR-specific events.

ATR strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ATR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ATR alongside the broader basket even when ATR-specific fundamentals are unchanged. Always rebuild the position from current ATR chain quotes before placing a trade.

Frequently asked questions

What is a strangle on ATR?: A strangle on ATR is the strangle strategy applied to ATR (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With ATR stock trading near $114.83, the strikes shown on this page are snapped to the nearest listed ATR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are ATR strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the ATR strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 26.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$365.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ATR strangle?: The breakeven for the ATR strangle priced on this page is roughly $106.35 and $123.65 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ATR market-implied 1-standard-deviation expected move is approximately 7.60%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on ATR?: Strangles on ATR are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the ATR chain.
How does current ATR implied volatility affect this strangle?: ATR ATM IV is at 26.50% with IV rank near 8.51%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.